Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression
静脉注射 CpG7909 脂质体复合物可通过调节肿瘤微环境并诱导持久的肿瘤消退，从而增强抗 PD-1 免疫疗法的疗效。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-29622-x
Tu, Chia-Mu; Lin, Meng-Hsuan; Liu, Chih-Peng; Chen, Shih-Ta; Liu, Chun-Min; She, Meng-Ping; Wang, Yu-Cheng; Wang, Hsiang-Ching; Chang, Yuan-Chia; Chang, Li-Wen; Lo, Yo-Wen; Lin, Min-Xun; Cheng, Ping-Fu; Cheng, Felice; Chen, Jen-Kun; Meng, Jun-Lun; Wu, Ming-Hsi; Su, Yu-Cheng
